Details of the Drug

General Information of Drug (ID: DM6FKOW)

• Drug Name: MG-4101

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 2	[1]

• Cross-matching ID: TTD ID: D0F4UM

References

• [1] ClinicalTrials.gov (NCT02008929) to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell). U.S. National Institutes of Health.